Skip to main content
UKHSA data dashboard

BetaThis is a new service - your feedback will help us to improve it.

Information
Yellow heat health alerts issued for the East Midlands, East of England, London, South East and South West

Regions affected include the East Midlands, East of England, London, South East and South West from 12pm Saturday 4 July until 5pm Wednesday 8 July. For more information, please see the Weather health alerts page.

Entry title:

Antimicrobial resistance in Streptococcus pneumoniae (S. pneumoniae) bacteraemia

Last updated on Thursday, 25 June 2026 at 04:00pm

This page provides information on resistance to antimicrobials in Streptococcus pneumoniae bacteraemia (bacteria found in blood specimens). Data breakdowns are available for England and by UKHSA Region.

Filter results by location
Reset

Overview

Antibiotics are grouped based on the UK-AWaRe classification. These are:

Access
Access antibiotics are with a narrow spectrum of activity, fewer side effects, lower costs, and importantly lower resistance potential. These are first or second choice antibiotics recommended for empiric treatment of the most common infections and should be widely available. That is to say, these antibiotics should offer the best therapeutic value while minimizing the potential for resistance.

Watch
Watch antibiotics have a higher resistance potential and are broader-spectrum antibiotics. These are first or second choice antibiotics indicated for a limited number of infective syndromes. As these antibiotics are considered to have a higher potential for selection of AMR, their use should be carefully monitored.

Reserve
Reserve antibiotics are “last resort” antibiotics, including new antibiotics. These are used for highly selected patients (life-threatening infections due to multi-drug-resistant bacteria) and are closely monitored and prioritized as targets of stewardship programmes to ensure continued effectiveness.

Resistance

Rolling monthly average percent of S. pneumoniae bacteraemia resistant to macrolides and penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

ChartThere are 2 plots on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is plot number 1 on this chart. This is a dark blue solid line plot. The plot has a label of 'Macrolides (Watch)'. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 8.23 on 01 April 2021 to 6.16 on 01 February 2022. It rose from 5.41 on 01 March 2022 to 5.44 on 01 December 2022. It rose from 5.61 on 01 January 2023 to 7.54 on 01 October 2023. It rose from 7.41 on 01 November 2023 to 8.2 on 01 August 2024. It rose from 7.47 on 01 September 2024 to 9.12 on 01 June 2025. And finally. It rose from 9.92 on 01 July 2025 to 10.19 on 01 April 2026. This is plot number 2 on this chart. This is a turquoise solid line plot. The plot has a label of 'Penicillin (Access)'. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 2.58 on 01 April 2021 to 1.97 on 01 February 2022. It rose from 1.2 on 01 March 2022 to 2.36 on 01 December 2022. It fell from 1.72 on 01 January 2023 to 1.19 on 01 October 2023. It rose from 1.36 on 01 November 2023 to 2.53 on 01 August 2024. It rose from 2.44 on 01 September 2024 to 3.38 on 01 June 2025. And finally. It fell from 3.18 on 01 July 2025 to 2.84 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of S. pneumoniae bacteraemia resistant to macrolides and penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Macrolides (Watch) Penicillin (Access)
1 Apr 202610.192.84
1 Mar 202610.063.49
1 Feb 202610.543.43
1 Jan 20269.913.98
1 Dec 20258.883.49
1 Nov 20257.703.58
1 Oct 20259.422.99
1 Sep 202510.022.42
1 Aug 202510.103.02
1 Jul 20259.923.18
1 Jun 20259.123.38
1 May 20258.992.90
1 Apr 20257.852.66
1 Mar 20258.152.26
1 Feb 20257.832.17
1 Jan 20258.452.21
1 Dec 20248.462.10
1 Nov 20248.251.74
1 Oct 20247.701.29
1 Sep 20247.472.44
1 Aug 20248.202.53
1 Jul 20247.613.78
1 Jun 20247.073.77
1 May 20246.893.70
1 Apr 20247.502.75
1 Mar 20247.532.75
1 Feb 20247.262.31
1 Jan 20246.442.10
1 Dec 20236.841.42
1 Nov 20237.411.36
1 Oct 20237.541.19
1 Sep 20236.042.18
1 Aug 20235.032.42
1 Jul 20234.812.36
1 Jun 20236.302.14
1 May 20237.341.72
1 Apr 20237.931.75
1 Mar 20237.591.40
1 Feb 20235.811.43
1 Jan 20235.611.72
1 Dec 20225.442.36
1 Nov 20226.843.14
1 Oct 20226.932.73
1 Sep 20225.610.68
1 Aug 20226.280.98
1 Jul 20225.321.19
1 Jun 20224.591.29
1 May 20223.611.12
1 Apr 20224.461.02
1 Mar 20225.411.20
1 Feb 20226.161.97
1 Jan 20226.281.74
1 Dec 20217.312.27
1 Nov 20217.711.97
1 Oct 20217.231.92
1 Sep 20215.661.33
1 Aug 20216.221.73
1 Jul 20216.222.38
1 Jun 20217.322.39
1 May 20216.612.35
1 Apr 20218.232.58
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Macrolides

Testing

Rolling monthly average number of S. pneumoniae bacteraemia tested for resistance to macrolides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 81.0 on 01 April 2021 to 238.0 on 01 February 2022. It rose from 203.33 on 01 March 2022 to 447.0 on 01 December 2022. It fell from 487.33 on 01 January 2023 to 207.67 on 01 October 2023. It fell from 279.0 on 01 November 2023 to 215.33 on 01 August 2024. It rose from 183.0 on 01 September 2024 to 372.67 on 01 June 2025. And finally. It rose from 275.67 on 01 July 2025 to 396.0 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of S. pneumoniae bacteraemia tested for resistance to macrolides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026396.00
1 Mar 2026427.33
1 Feb 2026490.33
1 Jan 2026464.00
1 Dec 2025439.33
1 Nov 2025307.33
1 Oct 2025251.33
1 Sep 2025186.33
1 Aug 2025208.00
1 Jul 2025275.67
1 Jun 2025372.67
1 May 2025434.00
1 Apr 2025458.67
1 Mar 2025491.00
1 Feb 2025583.00
1 Jan 2025568.00
1 Dec 2024496.67
1 Nov 2024311.00
1 Oct 2024229.33
1 Sep 2024183.00
1 Aug 2024215.33
1 Jul 2024276.00
1 Jun 2024325.33
1 May 2024372.33
1 Apr 2024422.00
1 Mar 2024460.67
1 Feb 2024519.00
1 Jan 2024476.00
1 Dec 2023424.00
1 Nov 2023279.00
1 Oct 2023207.67
1 Sep 2023160.00
1 Aug 2023192.33
1 Jul 2023242.33
1 Jun 2023301.67
1 May 2023359.00
1 Apr 2023395.33
1 Mar 2023417.00
1 Feb 2023510.33
1 Jan 2023487.33
1 Dec 2022447.00
1 Nov 2022263.33
1 Oct 2022197.33
1 Sep 2022160.33
1 Aug 2022185.67
1 Jul 2022213.00
1 Jun 2022246.67
1 May 2022249.33
1 Apr 2022239.33
1 Mar 2022203.33
1 Feb 2022238.00
1 Jan 2022270.67
1 Dec 2021305.33
1 Nov 2021237.67
1 Oct 2021189.00
1 Sep 2021141.33
1 Aug 2021150.00
1 Jul 2021155.33
1 Jun 2021150.33
1 May 2021121.00
1 Apr 202181.00
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of S. pneumoniae bacteraemia tested for resistance to macrolides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 96.43 on 01 April 2021 to 95.2 on 01 February 2022. It rose from 93.55 on 01 March 2022 to 94.5 on 01 December 2022. It fell from 95.12 on 01 January 2023 to 92.0 on 01 October 2023. It rose from 91.48 on 01 November 2023 to 91.49 on 01 August 2024. It rose from 91.5 on 01 September 2024 to 92.08 on 01 June 2025. And finally. It rose from 92.28 on 01 July 2025 to 92.31 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of S. pneumoniae bacteraemia tested for resistance to macrolides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202692.31
1 Mar 202692.42
1 Feb 202691.93
1 Jan 202691.16
1 Dec 202590.70
1 Nov 202589.77
1 Oct 202590.94
1 Sep 202591.63
1 Aug 202593.27
1 Jul 202592.28
1 Jun 202592.08
1 May 202591.56
1 Apr 202591.24
1 Mar 202591.78
1 Feb 202591.81
1 Jan 202591.91
1 Dec 202491.51
1 Nov 202491.47
1 Oct 202491.97
1 Sep 202491.50
1 Aug 202491.49
1 Jul 202492.00
1 Jun 202491.55
1 May 202492.31
1 Apr 202492.34
1 Mar 202493.12
1 Feb 202493.35
1 Jan 202492.61
1 Dec 202392.37
1 Nov 202391.48
1 Oct 202392.00
1 Sep 202390.91
1 Aug 202391.43
1 Jul 202392.02
1 Jun 202392.90
1 May 202394.23
1 Apr 202394.27
1 Mar 202394.99
1 Feb 202394.80
1 Jan 202395.12
1 Dec 202294.50
1 Nov 202294.27
1 Oct 202293.81
1 Sep 202294.67
1 Aug 202295.36
1 Jul 202295.09
1 Jun 202294.25
1 May 202293.61
1 Apr 202294.09
1 Mar 202293.55
1 Feb 202295.20
1 Jan 202294.41
1 Dec 202195.02
1 Nov 202194.80
1 Oct 202194.97
1 Sep 202194.63
1 Aug 202193.75
1 Jul 202193.37
1 Jun 202193.75
1 May 202195.28
1 Apr 202196.43
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of S. pneumoniae bacteraemia resistant to macrolides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 8.23 on 01 April 2021 to 6.16 on 01 February 2022. It rose from 5.41 on 01 March 2022 to 5.44 on 01 December 2022. It rose from 5.61 on 01 January 2023 to 7.54 on 01 October 2023. It rose from 7.41 on 01 November 2023 to 8.2 on 01 August 2024. It rose from 7.47 on 01 September 2024 to 9.12 on 01 June 2025. And finally. It rose from 9.92 on 01 July 2025 to 10.19 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of S. pneumoniae bacteraemia resistant to macrolides. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 202610.19
1 Mar 202610.06
1 Feb 202610.54
1 Jan 20269.91
1 Dec 20258.88
1 Nov 20257.70
1 Oct 20259.42
1 Sep 202510.02
1 Aug 202510.10
1 Jul 20259.92
1 Jun 20259.12
1 May 20258.99
1 Apr 20257.85
1 Mar 20258.15
1 Feb 20257.83
1 Jan 20258.45
1 Dec 20248.46
1 Nov 20248.25
1 Oct 20247.70
1 Sep 20247.47
1 Aug 20248.20
1 Jul 20247.61
1 Jun 20247.07
1 May 20246.89
1 Apr 20247.50
1 Mar 20247.53
1 Feb 20247.26
1 Jan 20246.44
1 Dec 20236.84
1 Nov 20237.41
1 Oct 20237.54
1 Sep 20236.04
1 Aug 20235.03
1 Jul 20234.81
1 Jun 20236.30
1 May 20237.34
1 Apr 20237.93
1 Mar 20237.59
1 Feb 20235.81
1 Jan 20235.61
1 Dec 20225.44
1 Nov 20226.84
1 Oct 20226.93
1 Sep 20225.61
1 Aug 20226.28
1 Jul 20225.32
1 Jun 20224.59
1 May 20223.61
1 Apr 20224.46
1 Mar 20225.41
1 Feb 20226.16
1 Jan 20226.28
1 Dec 20217.31
1 Nov 20217.71
1 Oct 20217.23
1 Sep 20215.66
1 Aug 20216.22
1 Jul 20216.22
1 Jun 20217.32
1 May 20216.61
1 Apr 20218.23
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Penicillin

Testing

Rolling monthly average number of S. pneumoniae bacteraemia tested for resistance to penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 77.67 on 01 April 2021 to 219.67 on 01 February 2022. It rose from 194.33 on 01 March 2022 to 409.33 on 01 December 2022. It fell from 445.67 on 01 January 2023 to 196.67 on 01 October 2023. It fell from 269.0 on 01 November 2023 to 197.67 on 01 August 2024. It rose from 163.67 on 01 September 2024 to 335.0 on 01 June 2025. And finally. It rose from 241.0 on 01 July 2025 to 352.33 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of S. pneumoniae bacteraemia tested for resistance to penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026352.33
1 Mar 2026382.33
1 Feb 2026437.67
1 Jan 2026418.67
1 Dec 2025391.33
1 Nov 2025279.33
1 Oct 2025223.33
1 Sep 2025165.33
1 Aug 2025176.67
1 Jul 2025241.00
1 Jun 2025335.00
1 May 2025391.00
1 Apr 2025413.00
1 Mar 2025442.00
1 Feb 2025536.67
1 Jan 2025528.00
1 Dec 2024461.33
1 Nov 2024287.33
1 Oct 2024206.33
1 Sep 2024163.67
1 Aug 2024197.67
1 Jul 2024255.67
1 Jun 2024301.00
1 May 2024342.33
1 Apr 2024388.33
1 Mar 2024424.67
1 Feb 2024476.00
1 Jan 2024445.33
1 Dec 2023398.00
1 Nov 2023269.00
1 Oct 2023196.67
1 Sep 2023152.67
1 Aug 2023179.00
1 Jul 2023225.67
1 Jun 2023281.00
1 May 2023329.67
1 Apr 2023361.33
1 Mar 2023381.67
1 Feb 2023467.33
1 Jan 2023445.67
1 Dec 2022409.33
1 Nov 2022244.00
1 Oct 2022183.33
1 Sep 2022146.00
1 Aug 2022170.67
1 Jul 2022196.67
1 Jun 2022233.00
1 May 2022237.67
1 Apr 2022228.67
1 Mar 2022194.33
1 Feb 2022219.67
1 Jan 2022248.67
1 Dec 2021279.33
1 Nov 2021219.67
1 Oct 2021173.33
1 Sep 2021125.33
1 Aug 2021135.00
1 Jul 2021140.33
1 Jun 2021139.67
1 May 2021113.33
1 Apr 202177.67
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of S. pneumoniae bacteraemia tested for resistance to penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 91.67 on 01 April 2021 to 87.6 on 01 February 2022. It fell from 89.4 on 01 March 2022 to 86.47 on 01 December 2022. It rose from 86.91 on 01 January 2023 to 87.11 on 01 October 2023. It fell from 88.2 on 01 November 2023 to 83.83 on 01 August 2024. It rose from 81.5 on 01 September 2024 to 82.92 on 01 June 2025. And finally. It rose from 80.87 on 01 July 2025 to 82.05 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of S. pneumoniae bacteraemia tested for resistance to penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202682.05
1 Mar 202682.68
1 Feb 202681.99
1 Jan 202682.12
1 Dec 202580.79
1 Nov 202581.58
1 Oct 202580.80
1 Sep 202581.28
1 Aug 202578.92
1 Jul 202580.87
1 Jun 202582.92
1 May 202582.49
1 Apr 202582.27
1 Mar 202582.62
1 Feb 202584.41
1 Jan 202585.44
1 Dec 202485.06
1 Nov 202484.41
1 Oct 202482.73
1 Sep 202481.50
1 Aug 202483.83
1 Jul 202485.00
1 Jun 202484.79
1 May 202484.86
1 Apr 202484.90
1 Mar 202485.83
1 Feb 202485.61
1 Jan 202486.58
1 Dec 202386.71
1 Nov 202388.20
1 Oct 202387.11
1 Sep 202386.36
1 Aug 202385.24
1 Jul 202385.55
1 Jun 202386.73
1 May 202386.35
1 Apr 202386.16
1 Mar 202386.79
1 Feb 202386.80
1 Jan 202386.91
1 Dec 202286.47
1 Nov 202287.46
1 Oct 202287.14
1 Sep 202286.39
1 Aug 202287.63
1 Jul 202287.50
1 Jun 202289.27
1 May 202289.10
1 Apr 202289.76
1 Mar 202289.40
1 Feb 202287.60
1 Jan 202286.71
1 Dec 202186.92
1 Nov 202187.60
1 Oct 202186.93
1 Sep 202183.89
1 Aug 202184.38
1 Jul 202184.34
1 Jun 202186.88
1 May 202188.98
1 Apr 202191.67
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of S. pneumoniae bacteraemia resistant to penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for S-pneumoniae. Specifically the metric 's-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 2.58 on 01 April 2021 to 1.97 on 01 February 2022. It rose from 1.2 on 01 March 2022 to 2.36 on 01 December 2022. It fell from 1.72 on 01 January 2023 to 1.19 on 01 October 2023. It rose from 1.36 on 01 November 2023 to 2.53 on 01 August 2024. It rose from 2.44 on 01 September 2024 to 3.38 on 01 June 2025. And finally. It fell from 3.18 on 01 July 2025 to 2.84 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of S. pneumoniae bacteraemia resistant to penicillin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 20262.84
1 Mar 20263.49
1 Feb 20263.43
1 Jan 20263.98
1 Dec 20253.49
1 Nov 20253.58
1 Oct 20252.99
1 Sep 20252.42
1 Aug 20253.02
1 Jul 20253.18
1 Jun 20253.38
1 May 20252.90
1 Apr 20252.66
1 Mar 20252.26
1 Feb 20252.17
1 Jan 20252.21
1 Dec 20242.10
1 Nov 20241.74
1 Oct 20241.29
1 Sep 20242.44
1 Aug 20242.53
1 Jul 20243.78
1 Jun 20243.77
1 May 20243.70
1 Apr 20242.75
1 Mar 20242.75
1 Feb 20242.31
1 Jan 20242.10
1 Dec 20231.42
1 Nov 20231.36
1 Oct 20231.19
1 Sep 20232.18
1 Aug 20232.42
1 Jul 20232.36
1 Jun 20232.14
1 May 20231.72
1 Apr 20231.75
1 Mar 20231.40
1 Feb 20231.43
1 Jan 20231.72
1 Dec 20222.36
1 Nov 20223.14
1 Oct 20222.73
1 Sep 20220.68
1 Aug 20220.98
1 Jul 20221.19
1 Jun 20221.29
1 May 20221.12
1 Apr 20221.02
1 Mar 20221.20
1 Feb 20221.97
1 Jan 20221.74
1 Dec 20212.27
1 Nov 20211.97
1 Oct 20211.92
1 Sep 20211.33
1 Aug 20211.73
1 Jul 20212.38
1 Jun 20212.39
1 May 20212.35
1 Apr 20212.58
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Related content

Learn more about UKHSA data dashboard topics